SARA SIGLER: Open Payments
NPI 1770968091 · GROVEPORT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 9 payments from 8 companies in 2025. Trend: 2023 $1,317 · 2024 $65 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| ViiV Healthcare Company | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: JOURNAVX, REXULTI, CAPLYTA, APRETUDE, Kerendia, VERQUVO, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
